OncoQuest Pharmaceuticals Inc (078590) — Cash Flow Quality Index
OncoQuest Pharmaceuticals Inc (078590) has a Cash Flow Quality Index of -0.21x as of June 2025. Operating cash flow of ₩-303.65 Million is below net income of ₩1.46 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore OncoQuest Pharmaceuticals Inc (078590) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
OncoQuest Pharmaceuticals Inc Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for OncoQuest Pharmaceuticals Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of OncoQuest Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for OncoQuest Pharmaceuticals Inc (2014–2024)
Year-by-year earnings quality comparison for OncoQuest Pharmaceuticals Inc. For live market cap and the full company financial profile, see 078590 market cap.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.86x | ₩3.96 Billion | ₩4.60 Billion | ▼ -36.8% |
| 2023 | 1.36x | ₩11.19 Billion | ₩8.20 Billion | ▲ +5704.1% |
| 2022 | -0.02x | ₩-236.91 Million | ₩9.73 Billion | ▼ -101.3% |
| 2017 | 1.84x | ₩4.79 Billion | ₩2.60 Billion | ▲ +29.9% |
| 2016 | 1.42x | ₩3.54 Billion | ₩2.49 Billion | ▼ -32.9% |
| 2015 | 2.12x | ₩2.79 Billion | ₩1.32 Billion | ▲ +40.9% |
| 2014 | 1.50x | ₩1.02 Billion | ₩675.61 Million | — |